Joseph A. Paladino - Concepedia

Author

Joseph A. Paladino

University at Buffalo, State University of New York ORCID

Also Known As

J A Paladino, J PALADINO, J Paladino, J. A. Paladino, J. PALADINO, J. Paladino, J.A. Paladino, JOSEPH PALADINO, Jordan Paladino, Joseph A Paladino

113

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

University at Buffalo, State University of New York Millard Fillmore Suburban Hospital Kaleida Health Servier (France)Inserm

About

Joseph A. Paladino is an author at University at Buffalo, State University of New York specializing in medicine, antimicrobial resistance, and antibiotics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	25	1.5K
2	Health Sciences	7	7	471
3	Public Health	4	4	165
4	Engineering	3	3	58
5	Natural Sciences	1	1	11

Joseph A. Paladino

Publications

Citations

H-Index

Page 1

	Year	Citations
Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections Peggy S. McKinnon, Joseph A. Paladino, Jerome J. Schentag International Journal of Antimicrobial Agents Serious Bacterial InfectionsMinimum Inhibitory ConcentrationAntimicrobial SusceptibilityAntimicrobial StewardshipMedicine	2008	455
Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics Joseph A. Paladino, Howard E. Sperry, Julie M. Backes, The American Journal of Medicine Antimicrobial StewardshipAntibioticsOral CiprofloxacinPatient SafetyAbbreviated Course	1991	163
Genesis of Methicillin‐Resistant<i>Staphylococcus aureus</i>(MRSA), How Treatment of MRSA Infections Has Selected for Vancomycin‐Resistant<i>Enterococcus faecium,</i>and the Importance of Antibiotic Management and Infection Control Jerome J. Schentag, Judith M. Hyatt, James R. Carr, Clinical Infectious Diseases Enterococcus FaeciumAntibiotic ResistanceDrug ResistanceAntimicrobial StewardshipHealthcare-associated Infection	1998	139
Changes in antimicrobial agent usage resulting from interactions among clinical pharmacy, the infectious disease division, and the microbiology laboratory Jerome J. Schentag, Charles H. Ballow, Albert L. Fritz, Diagnostic Microbiology and Infectious Disease Anti-infective AgentsHealth SciencesAntibioticsInfectious Disease DivisionMedicine	1993	124
Impact of Rapid Methicillin-Resistant Staphylococcus aureus Polymerase Chain Reaction Testing on Mortality and Cost Effectiveness in Hospitalized Patients with Bacteraemia Jack Brown, Joseph A. Paladino PharmacoEconomics Antimicrobial SusceptibilityHealth SciencesDrug ResistanceHealthcare-associated InfectionPatient Safety	2010	93
Cost-effectiveness of Gatifloxacin vs Ceftriaxone With a Macrolide for the Treatment of Community-Acquired Pneumonia Linda Dresser, Michael S. Niederman, Joseph A. Paladino CHEST Journal Community-acquired PneumoniaAntimicrobial StewardshipAntibioticsMedicineAntimicrobial Chemotherapy	2001	82
Benchmark analysis of strategies hospitals use to control antimicrobial expenditures Robert P. Rifenburg, Joseph A. Paladino, Stephen C. Hanson, American Journal of Health-System Pharmacy Pharmacy ExpendituresHospital ExpendituresBenchmark AnalysisHospital MedicineAntimicrobial Stewardship	1996	73
Clinical Efficacy of Intravenous followed by Oral Azithromycin Monotherapy in Hospitalized Patients with Community-Acquired Pneumonia Joseph F. Plouffe, Douglas B. Schwartz, Antonia Kolokathis, Antimicrobial Agents and Chemotherapy	2000	70
Cost-Effectiveness of Ampicillin/Sulbactam Versus Imipenem/Cilastatin in the Treatment of Limb-Threatening Foot Infections in Diabetic Patients Peggy S. McKinnon, Joseph A. Paladino, M. Lindsay Grayson, Clinical Infectious Diseases	1997	55
Effect of fluoroquinolone expenditures on susceptibility of Pseudomonas aeruginosa to ciprofloxacin in U.S. hospitals Sujata M. Bhavnani, Wendy A. Callen, Alan Forrest, American Journal of Health-System Pharmacy Antimicrobial SusceptibilityHealth SciencesAntibioticsAntimicrobial StewardshipDrug Resistance	2003	39

Page 1